Universal Ibogaine (TSXV:IBO) Net Income (Continuing Operations) : C$-1.19 Mil (TTM As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Universal Ibogaine's Net Income (Continuing Operations) for the three months ended in Jan. 2024 was C$-0.22 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jan. 2024 was C$-1.19 Mil.

Universal Ibogaine Net Income (Continuing Operations) Historical Data

The historical data trend for Universal Ibogaine's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Net Income (Continuing Operations) Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-0.10

-0.12

-0.29

-10.50

-2.39

Universal Ibogaine Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-0.79	-0.49	-0.27	-0.21	-0.22

Universal Ibogaine Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.19 Mil.

Universal Ibogaine (TSXV:IBO) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Universal Ibogaine Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine (TSXV:IBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Executives

Ian Rabb

Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines